Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2012

Open Access 01-12-2012 | Research

Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma

Authors: Toshiya Kamiyama, Kazuaki Nakanishi, Hideki Yokoo, Hirofumi Kamachi, Munenori Tahara, Tatsuhiko Kakisaka, Yosuke Tsuruga, Satoru Todo, Akinobu Taketomi

Published in: World Journal of Surgical Oncology | Issue 1/2012

Login to get access

Abstract

Background

Liver resection for hepatocellular carcinoma (HCC) has the highest local controllability among all local treatments and results in a good survival rate. However, the recurrence rates of HCC continue to remain high even after curative hepatectomy Moreover, it has been reported that some patients with HCC have an early death due to recurrence. We analyzed the preoperative risk factors for early cancer death.

Methods

Between 1997 and 2009, 521 consecutive patients who underwent hepatectomy for HCC at our center were assigned to group ED (death due to HCC recurrence or progression within 1 year after hepatectomy) and group NED (alive over 1 year after hepatectomy). Risk factors for early cancer death were analyzed.

Results

Group ED included 48 patients, and group NED included 473 patients. The cause of death included cancer progression (150; 78.1%), operation-related (1; 0.5%), hepatic failure (15; 7.8%), and other (26; 13.5%). Between the ED and NED groups, there were significant differences in albumin levels, Child-Pugh classifications, anatomical resections, curability, tumor numbers, tumor sizes, macroscopic vascular invasion (portal vein and hepatic vein), alpha-fetoprotein (AFP) levels, AFP-L3 levels, protein induced by vitamin K absence or antagonism factor II (PIVKA-II) levels, differentiation, microscopic portal vein invasion, microscopic hepatic vein invasion, and distant metastasis by univariate analysis. Multivariate analysis identified specific risk factors, such as AFP level > 1,000 ng/ml, tumor number ≥ 4, tumor size ≥ 5 cm, poor differentiation, and portal vein invasion. With respect to the preoperative risk factors such as AFP level, tumor number, and tumor size, 3 (1.1%) of 280 patients with no risk factors, 12 (7.8%) of 153 patients with 1 risk factor, 24 (32.9%) of 73 patients with 2 factors, and 9 (60.0%) of 15 patients with 3 risk factors died within 1 year of hepatectomy (p < 0.0001).

Conclusions

Hepatectomy should be judiciously selected for patients with AFP level > 1,000 ng/ml, tumor number ≥ 4, and tumor size ≥ 5 cm, because patients with these preoperative risk factors tend to die within 1 year after hepatectomy; these patients might be better treated with other therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K, Yamada R: Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology. 2000, 32: 1224-1229. 10.1053/jhep.2000.20456.CrossRefPubMed Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K, Yamada R: Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology. 2000, 32: 1224-1229. 10.1053/jhep.2000.20456.CrossRefPubMed
2.
go back to reference Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M: Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg. 2005, 242: 252-259. 10.1097/01.sla.0000171307.37401.db.PubMedCentralCrossRefPubMed Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M: Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg. 2005, 242: 252-259. 10.1097/01.sla.0000171307.37401.db.PubMedCentralCrossRefPubMed
3.
go back to reference Kamiyama T, Nakanishi K, Yokoo H, Kamachi H, Tahara M, Suzuki T, Shimamura T, Furukawa H, Matsushita M, Todo S: Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization. Ann Surg Oncol. 2009, 16: 1560-1571. 10.1245/s10434-009-0407-7.CrossRefPubMed Kamiyama T, Nakanishi K, Yokoo H, Kamachi H, Tahara M, Suzuki T, Shimamura T, Furukawa H, Matsushita M, Todo S: Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization. Ann Surg Oncol. 2009, 16: 1560-1571. 10.1245/s10434-009-0407-7.CrossRefPubMed
4.
go back to reference Kondo K, Chijiiwa K, Makino I, Kai M, Maehara N, Ohuchida J, Naganuma S: Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2005, 12: 399-404. 10.1007/s00534-005-1009-9.CrossRefPubMed Kondo K, Chijiiwa K, Makino I, Kai M, Maehara N, Ohuchida J, Naganuma S: Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2005, 12: 399-404. 10.1007/s00534-005-1009-9.CrossRefPubMed
5.
go back to reference Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, Tsuneyoshi M: Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology. 1995, 108: 768-775. 10.1016/0016-5085(95)90450-6.CrossRefPubMed Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, Tsuneyoshi M: Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology. 1995, 108: 768-775. 10.1016/0016-5085(95)90450-6.CrossRefPubMed
6.
go back to reference Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S, Makuuchi M: Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003, 38: 200-207.CrossRefPubMed Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S, Makuuchi M: Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003, 38: 200-207.CrossRefPubMed
7.
go back to reference Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J: Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000, 89: 500-507. 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O.CrossRefPubMed Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J: Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000, 89: 500-507. 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O.CrossRefPubMed
8.
go back to reference Ikeda Y, Kajiyama K, Adachi E, Yamagata M, Shimada M, Yanaga K: Early recurrence after surgery of hepatocellular carcinoma. Hepatogastroenterology. 1995, 42: 469-472.PubMed Ikeda Y, Kajiyama K, Adachi E, Yamagata M, Shimada M, Yanaga K: Early recurrence after surgery of hepatocellular carcinoma. Hepatogastroenterology. 1995, 42: 469-472.PubMed
9.
go back to reference Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepato. 2001, 35: 421-430. 10.1016/S0168-8278(01)00130-1.CrossRef Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepato. 2001, 35: 421-430. 10.1016/S0168-8278(01)00130-1.CrossRef
10.
go back to reference Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S, Kawasaki S, Matsuyama Y, Okazaki M, Okita K, Omata M, Saida Y, Takayama T, Yamaoka Y: Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res. 2008, 38: 37-51. 10.1111/j.1872-034X.2007.00216.x.CrossRefPubMed Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S, Kawasaki S, Matsuyama Y, Okazaki M, Okita K, Omata M, Saida Y, Takayama T, Yamaoka Y: Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res. 2008, 38: 37-51. 10.1111/j.1872-034X.2007.00216.x.CrossRefPubMed
11.
go back to reference Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, Ikai I, Yamaoka Y, Belghiti J: Risk factors for early death due torecurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol. 2004, 85: 36-41. 10.1002/jso.10284.CrossRefPubMed Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, Ikai I, Yamaoka Y, Belghiti J: Risk factors for early death due torecurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol. 2004, 85: 36-41. 10.1002/jso.10284.CrossRefPubMed
12.
go back to reference Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008, 359: 378-390. 10.1056/NEJMoa0708857.CrossRefPubMed Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008, 359: 378-390. 10.1056/NEJMoa0708857.CrossRefPubMed
13.
go back to reference Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, Taylor BR, Grant DR, Vollmer CM: Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg. 2006, 202: 275-283. 10.1016/j.jamcollsurg.2005.10.005.CrossRefPubMed Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, Taylor BR, Grant DR, Vollmer CM: Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg. 2006, 202: 275-283. 10.1016/j.jamcollsurg.2005.10.005.CrossRefPubMed
14.
go back to reference Adachi E, Maeda T, Kajiyama K, Kinukawa N, Matsumata T, Sugimachi K, Tsuneyoshi M: Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer. 1996, 77: 2022-2031. 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S.CrossRefPubMed Adachi E, Maeda T, Kajiyama K, Kinukawa N, Matsumata T, Sugimachi K, Tsuneyoshi M: Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer. 1996, 77: 2022-2031. 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S.CrossRefPubMed
15.
go back to reference Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K, Yamasaki S: Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology. 1993, 40: 328-332.PubMed Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K, Yamasaki S: Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology. 1993, 40: 328-332.PubMed
16.
go back to reference Lai EC, You KT, Ng IO, Shek TW: The pathological basis of resection margin for hepatocellular carcinoma. World J Surg. 1993, 17: 790-discussion 91 Lai EC, You KT, Ng IO, Shek TW: The pathological basis of resection margin for hepatocellular carcinoma. World J Surg. 1993, 17: 790-discussion 91
17.
go back to reference Yang LY, Wang W, Peng JX, Yang JQ, Huang GW: Differentially expressed genes between solitary large hepatocellular carcinoma and nodular hepatocellular carcinoma. World J Gastroenterol. 2004, 10: 3569-3573.PubMed Yang LY, Wang W, Peng JX, Yang JQ, Huang GW: Differentially expressed genes between solitary large hepatocellular carcinoma and nodular hepatocellular carcinoma. World J Gastroenterol. 2004, 10: 3569-3573.PubMed
18.
go back to reference Wang W, Yang LY, Huang GW, Lu WQ, Yang ZL, Yang JQ, Liu HL: Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Br J Cancer. 2004, 90: 2349-2355.PubMedCentralPubMed Wang W, Yang LY, Huang GW, Lu WQ, Yang ZL, Yang JQ, Liu HL: Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Br J Cancer. 2004, 90: 2349-2355.PubMedCentralPubMed
19.
go back to reference Nomura F, Ohnishi K, Tanabe Y: Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer. 1989, 64: 1700-1707. 10.1002/1097-0142(19891015)64:8<1700::AID-CNCR2820640824>3.0.CO;2-Z.CrossRefPubMed Nomura F, Ohnishi K, Tanabe Y: Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer. 1989, 64: 1700-1707. 10.1002/1097-0142(19891015)64:8<1700::AID-CNCR2820640824>3.0.CO;2-Z.CrossRefPubMed
20.
go back to reference Hanazaki K, Kajikawa S, Koide N, Adachi W, Amano J: Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis. Am J Gastroenterol. 2001, 96: 1243-1250. 10.1111/j.1572-0241.2001.03634.x.CrossRefPubMed Hanazaki K, Kajikawa S, Koide N, Adachi W, Amano J: Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis. Am J Gastroenterol. 2001, 96: 1243-1250. 10.1111/j.1572-0241.2001.03634.x.CrossRefPubMed
21.
go back to reference Matsumoto Y, Suzuki T, Asada I, Ozawa K, Tobe T, Honjo I: Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels. Cancer. 1982, 49: 354-360. 10.1002/1097-0142(19820115)49:2<354::AID-CNCR2820490224>3.0.CO;2-J.CrossRefPubMed Matsumoto Y, Suzuki T, Asada I, Ozawa K, Tobe T, Honjo I: Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels. Cancer. 1982, 49: 354-360. 10.1002/1097-0142(19820115)49:2<354::AID-CNCR2820490224>3.0.CO;2-J.CrossRefPubMed
22.
go back to reference Smith JB: Occurrence of alpha-fetoprotein in acute viral hepatitis. Int J Cancer. 1971, 8: 421-424.CrossRefPubMed Smith JB: Occurrence of alpha-fetoprotein in acute viral hepatitis. Int J Cancer. 1971, 8: 421-424.CrossRefPubMed
23.
go back to reference Silver HK, Gold P, Shuster J, Javitt NB, Freedman SO, Finlayson ND: Alpha(1)-fetoprotein in chronic liver disease. N Engl J Med. 1974, 291: 506-508. 10.1056/NEJM197409052911006.CrossRefPubMed Silver HK, Gold P, Shuster J, Javitt NB, Freedman SO, Finlayson ND: Alpha(1)-fetoprotein in chronic liver disease. N Engl J Med. 1974, 291: 506-508. 10.1056/NEJM197409052911006.CrossRefPubMed
24.
go back to reference Fujiyama S, Tanaka M, Maeda S, Ashihara H, Hirata R, Tomita K: Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma. Oncology. 2002, 62 (Suppl 1): 57-63.CrossRefPubMed Fujiyama S, Tanaka M, Maeda S, Ashihara H, Hirata R, Tomita K: Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma. Oncology. 2002, 62 (Suppl 1): 57-63.CrossRefPubMed
25.
go back to reference Lok AS, Lai CL: Alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology. 1989, 9: 110-115. 10.1002/hep.1840090119.CrossRefPubMed Lok AS, Lai CL: Alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology. 1989, 9: 110-115. 10.1002/hep.1840090119.CrossRefPubMed
26.
go back to reference Yamanaka J, Yamanaka N, Nakasho K, Tanaka T, Ando T, Yasui C, Kuroda N, Takata M, Maeda S, Matsushita K, Uematsu K, Okamoto E: Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection. Gastroenterol Hepatol. 2000, 15: 1192-1198. 10.1046/j.1440-1746.2000.02323.x.CrossRef Yamanaka J, Yamanaka N, Nakasho K, Tanaka T, Ando T, Yasui C, Kuroda N, Takata M, Maeda S, Matsushita K, Uematsu K, Okamoto E: Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection. Gastroenterol Hepatol. 2000, 15: 1192-1198. 10.1046/j.1440-1746.2000.02323.x.CrossRef
27.
go back to reference Takayasu K, Arii S, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Kokudo N, Makuuchi M: Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines. J Hepatol. 2012, 56: 886-892. 10.1016/j.jhep.2011.10.021.CrossRefPubMed Takayasu K, Arii S, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Kokudo N, Makuuchi M: Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines. J Hepatol. 2012, 56: 886-892. 10.1016/j.jhep.2011.10.021.CrossRefPubMed
28.
go back to reference Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Bru C, Rodes J, Bruix J: Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999, 29: 62-67. 10.1002/hep.510290145.CrossRefPubMed Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Bru C, Rodes J, Bruix J: Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999, 29: 62-67. 10.1002/hep.510290145.CrossRefPubMed
29.
go back to reference Kamiyama T, Nakanishi K, Yokoo H, Tahara M, Nakagawa T, Kamachi H, Taguchi H, Shirato H, Matsushita M, Todo S: Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma. Int J Clin Oncol. 2007, 12: 363-368. 10.1007/s10147-007-0701-y.CrossRefPubMed Kamiyama T, Nakanishi K, Yokoo H, Tahara M, Nakagawa T, Kamachi H, Taguchi H, Shirato H, Matsushita M, Todo S: Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma. Int J Clin Oncol. 2007, 12: 363-368. 10.1007/s10147-007-0701-y.CrossRefPubMed
30.
go back to reference Minagawa M, Makuuchi M, Takayama T, Ohtomo K: Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg. 2001, 233: 379-384. 10.1097/00000658-200103000-00012.PubMedCentralCrossRefPubMed Minagawa M, Makuuchi M, Takayama T, Ohtomo K: Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg. 2001, 233: 379-384. 10.1097/00000658-200103000-00012.PubMedCentralCrossRefPubMed
31.
go back to reference Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, Ota H, Nakamura M, Wada H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshit K, Nakamori S, Monden M: Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch. Hepatogastroenterology. 2007, 54: 172-179.PubMed Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, Ota H, Nakamura M, Wada H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshit K, Nakamori S, Monden M: Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch. Hepatogastroenterology. 2007, 54: 172-179.PubMed
Metadata
Title
Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma
Authors
Toshiya Kamiyama
Kazuaki Nakanishi
Hideki Yokoo
Hirofumi Kamachi
Munenori Tahara
Tatsuhiko Kakisaka
Yosuke Tsuruga
Satoru Todo
Akinobu Taketomi
Publication date
01-12-2012
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2012
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-10-107

Other articles of this Issue 1/2012

World Journal of Surgical Oncology 1/2012 Go to the issue